Phibro Animal Health (PAHC) Current Taxes (2019 - 2026)
Phibro Animal Health's (PAHC) quarterly Current Taxes came in at $12.5 million in Q1 2026, up 96.55% year-on-year from $6.3 million in Q1 2025, and up 16.94% quarter-over-quarter from $10.7 million in Q4 2025.
Phibro Animal Health (PAHC) Current Taxes (2019 - 2026) Analysis & Trends
Phibro Animal Health's Current Taxes history runs 8 years deep, the most recent figure standing at $12.5 million for Q1 2026.
- On a quarterly basis, Current Taxes rose 96.55% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $12.5 million, a 96.55% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 186.49% from the prior year.
- Current Taxes climbed to $12.5 million in Q1 2026 per PAHC's latest filing, from $10.7 million in the prior quarter.
- Across five years, Current Taxes topped out at $12.5 million in Q1 2026 and bottomed at $2.9 million in Q2 2024.
- The 5-year median for Current Taxes is $7.2 million (2022), against an average of $7.2 million.
- Across the five-year window, Current Taxes plunged 66.17% in 2024 and jumped 186.49% in 2025, its largest moves.
- Year by year, Current Taxes stood at $7.2 million in 2022, then declined by 19.81% to $5.8 million in 2023, then slumped by 33.52% to $3.8 million in 2024, then surged by 178.52% to $10.7 million in 2025, then gained by 16.94% to $12.5 million in 2026.
- Per Business Quant, the three latest PAHC Current Taxes figures stand at $12.5 million (Q1 2026), $10.7 million (Q4 2025), and $10.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 12.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.48 Mn |
| Dec 31, 2025 | 10.67 Mn |
| Sep 30, 2025 | 10.61 Mn |
| Jun 30, 2025 | 8.40 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 5.29 Mn |
| Dec 31, 2023 | 5.76 Mn |
| Sep 30, 2023 | 5.95 Mn |
| Jun 30, 2023 | 8.66 Mn |
| Mar 31, 2023 | 7.62 Mn |
| Dec 31, 2022 | 7.19 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 7.21 Mn |
| Mar 31, 2022 | 7.89 Mn |
| Dec 31, 2021 | 6.53 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | 6.11 Mn |